Incintas Therapeutics

Incintas Therapeutics is a biotechnology company founded by Jesse Pizolato, Michael Barton, and Kun Zoo Kim in 2015 and is headquartered in Atglen, Pennsylvania.

Incintas Therapeutics works with scientists, physicians, and business professionals to develop effective infertility and in-vitro fertilization therapies to help families conceive. The company specializes in using genomic data to better determine the most likely times for pregnancy and successful in-vitro fertilization treatment while also developing methods of expanding the fertility window.